Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome
Safety of a regional standardized protocol to optimize the use of most effective platelet inhibition in ACS treated with PCI : Final Results from the Multicenter Rijnmond Collective Cardiology Study
Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes: results of the prospective randomized SWITCH OVER trial
Speaker:
Doctor F. Ottani (Vizzolo Predabissi, IT)
Is there gender-related outcome difference with oral dual antiplatelet therapy in patients with acute coronary syndromes? A systematic review and meta-analysis.